ChiCTR2200065417
尚未开始
/
/
/
2022-11-04
/
/
Parkinson's disease
Home-based dyadic mindfulness yoga programme for patients with Parkinson's disease and their caregivers
A home-based dyadic mindfulness yoga programme for patients with moderate-advanced Parkinson’s disease and their family caregivers: a feasibility trial
1) To examine the feasibility and preliminary effects of a dyadic mindfulness yoga programme compared with usual care on the primary outcome (depression) and secondary outcomes (anxiety, social support, mindfulness, functional balance, HRQOL, caregiver burden and PD-related motor and non-motor symptoms) among PwPD and caregivers at one week post-intervention (T1) and three month post-intervention. 2) To explore the experiences of Chinese PwPD and their family caregivers in using the dyadic mindfulness techniques for illness coping using a qualitative research approach.
随机平行对照
其它
After baseline assessment, dyads will be randomly assigned into one of the two groups on a 1:1 basis using the method of permuted block, with random block sizes between 4 and 8, and will be informed of their assigned group by an independent person not involved in assessment.
All outcome assessors will be blinded to subject allocation.
Seed Fund for Basic Research
/
30
/
2022-11-01
2025-06-30
/
We will recruit Chinese patients with idiopathic moderate-advanced PD (as indicated by the Hoehn and Yahr Scale stages III-IV: those with unilateral/bilateral symptoms, with/without postural instability who are able to walk or stand unassisted) and their family caregivers. For the patient, they need to be: 1. Aged between 50-80 years; 2. Experienced at least mild depressive symptoms–as indicated by a Patient Health Questionnaire-9 (PHQ-9) score >= 5 (15)–to ensure they are exposed to the core problem addressed by this study. As for the caregivers, they need to be self-identified as the primary co-residing caregivers of the patient counterparts for at least three months. Both of them need to be able to communicate in Cantonese. They will only be eligible if both the patient and caregiver in a dyad provide written consent to participate.;
登录查看Exclusion criteria are: 1. Have been engaged in regular systematic mind-body practices such as Tai Chi, qigong, yoga or other forms of mindfulness training (> 2 times per week) in the past 3 months; 2. Have pre-existing acute psychotic disease; 3. Are currently participating in any other behavioural or pharmacological trial; 4. Have significant cognitive impairment as indicated by the Abbreviated Mental Test score <= 6; 5. Have other contraindication(s) that may limit their full participation (e.g., severe hearing or vision impairment, etc.).;
登录查看The University of Hong Kong
/
TGF-β 胰腺导管腺癌
中国医药生物技术协会2025-06-18
肿瘤治疗性疫苗
医麦创新药2025-06-18
β-地中海贫血 β-地
医麦创新药2025-06-18
D&D Pharmatech Inc. GC GLP-1/GCG
药时空2025-06-18
MTAP PRMT5 AI
晶泰科技2025-06-18
肥胖 箕星 超重
箕星药业科技2025-06-18
β-地中海贫
邦耀实验室2025-06-18
抽动症 神经发育障碍 BD项目002
美柏资本2025-06-18